A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Jordan
Palatin
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Institute of Renal Research
Chula Vista, California, United States
- California Institute of Renal Research Dba - Balboa Research
La Mesa, California, United States
- Georgia Nephrology, Llc Dba -Ga Nephrology Research Institute
Decatur, Georgia, United States
- Georgia Nephrology, Llc [dba] Ga Nephrology Research Institute
Lawrenceville, Georgia, United States
- Brookview Hills Research Associates, Llc
Winston-Salem, North Carolina, United States
- Northeast Research Center, Llc
Bethlehem, Pennsylvania, United States
- Nephrotex Research Group
Dallas, Texas, United States
- Prolator Clinical Research Center
Houston, Texas, United States
- Clinical Advancement Center, Pllc
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Dec 2022
- Primary completion
- 26 Apr 2024
- Completion
- 26 Apr 2024
- Last update posted
- 17 Oct 2024
- Registered enrollment
- 16
- Registry id
- NCT05709444
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.